Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?
{{output}}
The lack of effective therapies for metastatic triple-negative breast cancer (mTNBC) highlights the need for the development of novel treatment strategies. The cornerstone of treatment has long been represented by chemotherapy. Relevant evidence has recently e... ...